| Literature DB >> 29954240 |
Yang Wang1,2,3, Jingzhou Hu1,2,3, Yan'an Wang1,2,3, Weimin Ye1,2,3, Xiangkai Zhang1,2,3, Houyu Ju1,2,3, Dongliang Xu4, Liu Liu1,2,3, Dongxia Ye1,2,3, Ling Zhang1,2,3, Dongwang Zhu1,2,3, Jiong Deng4, Zhiyuan Zhang1,2,3, Shuli Liu1,2,3.
Abstract
Epithelial-to-mesenchymal transition (EMT) confers cancer cells the ability of invasion and metastasis. However, how does EMT contribute to evasion of immune surveillance is unclear, especially in salivary adenoid cystic carcinoma (SACC). In this study, we investigated the molecular link between EGF-induced EMT and the immune checkpoint ligand programmed death-ligand 1 (PD-L1) by immunoprecipitation (IP) and Westernblot analysis. Cell migration and invasion activity was assayed by transwell assay. Immunohistochemical (IHC) staining analysis was performed for measurement of EMT markers and PD-L1 expression levels in tumor tissues. We found that EGF-induced EGFR activation stabilized Snail expression and induced EMT in SACC. Interestingly, EGFR activation induced simultaneously both EMT and PD-L1 in SACC. Importantly, knockdown of Snail greatly suppressed EGF-induced EMT, but not EGF-induced PD-L1 expression; whereas knockdown of c-Myc strongly repressed PD-L1 expression, but not snail expression and EMT. The molecular link is strongly supported by robust correlations between the EMT markers and PD-L1 expression in human cancer samples.These results suggest that EGFR activated EMT and PD-L1 via two distinct mechanisms. EGFR activation induced EMT and PD-L1 expression in SACC. Snail is required for EGF-induced EMT, but not PD-L1 expression; whereas c-Myc is required for EGFR-mediated PD-L1 upregulation but not EMT. Thus, targeting activated EGFR may inhibit both EMT and PD-L1, which may potentiate the therapeutic effect of PD-L1-based immunotherapy, especially in the malignant subgroups of SACC patients with activated EGFR.Entities:
Keywords: EMT; PD-L; SACC; Snail; c-Myc
Mesh:
Substances:
Year: 2018 PMID: 29954240 PMCID: PMC6132955 DOI: 10.1080/15384101.2018.1489177
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534